Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery

BACKGROUND: The aim was to evaluate the cost-effectiveness and cost–utility of ursodeoxycholic acid (UDCA) prophylaxis for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass (RYGB) in patients without gallstones before surgery. METHODS: Data from a multicentre, double-bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Haal, Sylke, Guman, Maimoena S S, de Brauw, L Maurits, Schouten, Ruben, van Veen, Ruben N, Fockens, Paul, Gerdes, Victor E A, Voermans, Rogier P, Dijkgraaf, Marcel G W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364680/
https://www.ncbi.nlm.nih.gov/pubmed/35979609
http://dx.doi.org/10.1093/bjs/znac273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364680/
https://www.ncbi.nlm.nih.gov/pubmed/35979609
http://dx.doi.org/10.1093/bjs/znac273

Ejemplares similares